StonvexLoading…
StonvexStonvexStonvexCore line items from AMRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $722.52M | $3.02B | $2.20B | $1.42B |
Operating Income | $141.77M | $394.10M | $282.06M | $211.72M |
Net Income | $62.26M | $72.06M | $36.98M | $34.61M |
EPS (Diluted) | $0.19 | $0.22 | $0.11 | $0.11 |
Total Assets | $3.54B | $3.68B | $3.60B | $3.42B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $197.66M | $282.03M | $201.25M | $71.54M |
Free Cash Flow OCF − CapEx | $-34.92M | $269.93M | $161.39M | $55.23M |
Shares Outstanding | 328.93M | 324.81M | 323.70M | 323.17M |